Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Aug;58(5):2087-2097.
doi: 10.1007/s00394-018-1766-2. Epub 2018 Jul 4.

Increased bioavailability of curcumin using a novel dispersion technology system (LipiSperse®)

D Briskey  1   2 , A Sax  3 , A R Mallard  4   5 , A Rao  5
Affiliations
Randomized Controlled Trial

Increased bioavailability of curcumin using a novel dispersion technology system (LipiSperse®)

D Briskey et al. Eur J Nutr. 2019 Aug.

Abstract

Purpose: Curcumin has been shown to deliver protective effects against numerous degenerative conditions associated with high levels of inflammation and oxidative stress. Owing to its poor bioavailability when delivered orally, it is difficult to deliver a high concentration therapeutic dose. LipiSperse® is a novel delivery system that uses dispersion technology to enhance bioavailability of hydrophobic agents. In this study, we investigated the pharmacokinetics of a commercially available curcumin extract, with or without the curcumin-LipiSperse® delivery complex.

Methods: Eighteen healthy male and female volunteers participated in this single equivalent dose, randomised, double-blinded study. Seven of those volunteers further participated in the crossover phase of the trial. Plasma concentrations were determined at baseline and at regular intervals over a 24-h period following 750 mg of curcuminoid ingestion.

Results: In both the parallel and crossover trial, Curcumin with LipiSperse® delivered significantly higher plasma curcuminoid concentrations compared to the raw curcumin product (807 vs 318 ng/mL in the crossover trial).

Conclusions: The novel delivery system LipiSperse® is safe in humans, and demonstrates superior bioavailability for the supply of curcumin when compared to a standard curcumin extract.

Keywords: Bioavailability; Curcumin; Curcuminoids; LipiSperse®; Pharmacokinetic.

PubMed Disclaimer

References

    1. Drug Metab Dispos. 1999 Apr;27(4):486-94 - PubMed
    1. Cancer Res. 2001 Feb 1;61(3):1058-64 - PubMed
    1. Clin Pharmacokinet. 2002;41(5):329-42 - PubMed
    1. Biochem Biophys Res Commun. 1991 Mar 29;175(3):880-5 - PubMed
    1. Carcinogenesis. 2007 Aug;28(8):1765-73 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources